ABEONA THERAPEUTICS |
5 000 |
0,08%
|
EURORDIS Round Table of Companies |
5 000 |
0,08% |
AEGLEA BIOTHERAPEUTICS |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
AGIOS |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
AKCEA THERAPEUTICS |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
ALEXION |
75 000 |
1,15% |
EURORDIS Black Pearl Awards |
10 000 |
0,15% |
European Conference on Rare Diseases |
15 000 |
0,23% |
EURORDIS International Initiatives |
25 000 |
0,38% |
EURORDIS Round Table of Companies
|
25 000 |
0,38% |
ALLIEVEX |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
ALNYLAM |
20 000 |
0,31% |
Black Pearl Awards |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
AMGEN EUROPE |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
AMICUS THERAPEUTICS |
20 000 |
0,31% |
Rare Barometer Voices |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
AMRYT |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
ARGENX |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
ASTELLAS |
14 000 |
0,22% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
AVROBIO |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
BAYER |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
BIOGEN |
55 000 |
0,84% |
Black Pearl Awards |
25 000 |
0,38% |
European Conference on Rare Diseases |
20 000 |
0,31% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
BIOMARIN |
29 000 |
0,45% |
European Conference on Rare Diseases |
15 000 |
0,23% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
BLUEBIRD BIO |
14 000 |
0,22% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
BLUEPRINT MEDICINES |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
BOEHRINGER INGELHEIM |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
BRIDGEBIO |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
BRISTOL-MYERS SQUIBB |
108 000 |
1,66% |
European Conference on Rare Diseases |
15 000 |
0,23% |
EURORDIS International Initiatives |
40 000 |
0,61% |
Rare Barometer Voices |
20 000 |
0,31% |
Rare Impact |
8 000 |
0,12% |
EURORDIS Round Table of Companies |
25 000 |
0,38% |
CHIESI |
74 000 |
1,14% |
Black Pearl Awards |
10 000 |
0,15% |
European Conference on Rare Diseases |
15 000 |
0,23% |
EURORDIS International Initiatives |
35 000 |
0,54% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
CSL BEHRING |
75 000 |
1,15% |
Black Pearl Awards |
20 000 |
0,31% |
European Conference on Rare Diseases |
15 000 |
0,23% |
Rare Barometer Voices |
15 000 |
0,23% |
EURORDIS Round Table of Companies |
25 000 |
0,38% |
CYTOKINETICS |
30 000 |
0,46% |
Black Pearl Awards |
20 000 |
0,31% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
DICERNA |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
ENZYVANT |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
GILEAD |
18 000 |
0,28% |
Rare Impact |
8 000 |
0,12% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
GLOBAL BLOOD THERAPEUTICS |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
GRIFOLS |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
LUNDBECK |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
HANSA BIOPHARMA |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
HORIZON THERAPEUTICS |
55 000 |
0,84% |
Black Pearl Awards |
20 000 |
0,31% |
EURORDIS International Initiatives |
25 000 |
0,38% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
INSMED |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
IPSEN |
30 000 |
0,46% |
European Conference on Rare Diseases |
20 000 |
0,31% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
JANSSEN, a pharmaceutical company of J&J |
75 000 |
1,15% |
Black Pearl Awards |
35 000 |
0,54% |
Rare Barometer Voices |
15 000 |
0,23% |
EURORDIS Round Table of Companies
|
25 000 |
0,38% |
JAZZ PHARMACEUTICALS |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
KYOWA KIRIN |
48 588 |
0,75% |
European Conference on Rare Diseases |
15 000 |
0,23% |
EURORDIS International Initiatives |
20 000 |
0,31% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
Unrestricted |
3 588 |
0,06% |
LEO PHARMA |
20 000 |
0,31% |
Rare Barometer Voices |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
LYSOGENE |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
MSD |
10 000 |
0,15% |
Round Table of Companies |
10 000 |
0,15% |
NEUROGENE |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
NOVARTIS |
73 000 |
1,12% |
European Conference on Rare Diseases |
15 000 |
0,23% |
EURORDIS International Initiatives |
25 000 |
0,38% |
Rare Impact |
8 000 |
0,12% |
EURORDIS Round Table of Companies |
25 000 |
0,38% |
NOVARTIS GENE THERAPIES |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
ORCHARD THERAPEUTICS |
24 000 |
0,37% |
European Conference on Rare Diseases |
15 000 |
0,23% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
OVID THERAPEUTICS |
15 000 |
0,23% |
EURORDIS Black Pearl Awards |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
PASSAGE BIO |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
PFIZER |
148 000 |
2,27% |
European Conference on Rare Diseases |
30 000 |
0,46% |
EURORDIS International Initiatives |
65 000 |
1,00% |
EURORDIS International Initiatives |
20 000 |
0,31% |
Rare Impact |
8 000 |
0,12% |
EURORDIS Round Table of Companies |
25 000 |
0,38% |
PROQR |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
PTC THERAPEUTICS |
54 000 |
0,83% |
European Conference on Rare Diseases |
15 000 |
0,23% |
EURORDIS International Initiatives |
25 000 |
0,38% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
RECORDATI RARE DISEASES |
35 000 |
0,54% |
Black Pearl Awards |
10 000 |
0,15% |
EURORDIS International Initiatives |
20 000 |
0,31% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
REGENXBIO |
9 000 |
0,14% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
ROCHE |
120 000 |
1,84% |
Black Pearl Awards |
25 000 |
0,38% |
European Conference on Rare Diseases |
15 000 |
0,23% |
EURORDIS International Initiatives |
40 000 |
0,61% |
Project Development |
15 000 |
0,23% |
EURORDIS Round Table of Companies |
25 000 |
0,38% |
SANGAMO |
9 000 |
0,14% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
SANOFI GENZYME |
95 000 |
1,46% |
Unrestricted |
7 000 |
0,11% |
European Conference on Rare Diseases |
15 000 |
0,23% |
EURORDIS International Initiatives |
40 000 |
0,61% |
Rare Impact |
8 000 |
0,12% |
EURORDIS Round Table of Companies |
25 000 |
0,38% |
SAREPTA THERAPEUTICS |
14 000 |
0,22% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
SOBI |
30 000 |
0,46% |
Black Pearl Awards |
10 000 |
0,15% |
Project Development |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
SPARK THERAPEUTICS |
9 000 |
0,14% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
TAKEDA |
188 000 |
2,89% |
European Conference on Rare Diseases |
30 000 |
0,46% |
EURORDIS International Initiatives |
85 000 |
1,31% |
Rare Barometer Voices |
40 000 |
0,61% |
Rare Impact |
8 000 |
0,12% |
EURORDIS Round Table of Companies |
25 000 |
0,38% |
TRAVERE THERAPEUTICS |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
UCB |
27 772 |
0,42% |
Unrestricted |
2 772 |
0,04% |
European Conference on Rare Diseases |
15 000 |
0,23% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
ULTRAGENYX |
4 000 |
0,06% |
Rare Impact |
4 000 |
0,06% |
VERTEX |
34 000 |
0,52% |
European Conference on Rare Diseases |
20 000 |
0,31% |
Rare Impact |
4 000 |
0,06% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
VIFOR PHARMA |
15 000 |
0,23% |
Black Pearl Awards |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
ZAMBON |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
Grand Total |
1 859 360 |
28,57% |
Other Health Sector Companies |
Company |
Amount (€) |
% of Revenue |
ALIRA HEALTH |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
APARITO |
1 200 |
0,02% |
Open Academy |
1 200 |
0,02% |
CLINIGEN |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
CYDAN |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
DRAVET SYNDROME FOUNDATION |
1 400 |
0,02% |
Open Academy |
1 400 |
0,02% |
HEALX |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
ICON |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
ILLUMINA |
30 000 |
0,46% |
Rare Barometer Voices |
20 000 |
0,31% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
IQVIA |
5 000 |
0,08% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
MAYO CLINIC |
4 500 |
0,07% |
Open Academy |
4 500 |
0,07% |
MEDICA TALENT GROUP |
8 000 |
0,12% |
Open Academy |
8 000 |
0,12% |
PAREXEL |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
10 000 |
0,15% |
QUALITY IMPROVEMENT CLINIC |
2 800 |
0,04% |
Open Academy |
2 800 |
0,04% |
VOZ ADVISORS |
15 000 |
0,23% |
Black Pearl Awards |
10 000 |
0,15% |
EURORDIS Round Table of Companies |
5 000 |
0,08% |
Grand Total |
107 900 |
1,66% |
|
|
|
Corporates Outside the Health Sector |
Company |
Amount (€) |
% of Revenue |
ANA MERLINO |
4 100 |
0,06% |
Open Academy |
4 100 |
0,06% |
CAPGEMINI |
1 000 |
0,02% |
Open Academy |
1 000 |
0,02% |
DLA PIPER |
50 891 |
0,78% |
Miscellaneous |
50 891 |
0,78% |
LAWYER GILLIAN AUSTIN |
443 |
0,01% |
Miscellaneous |
443 |
0,01% |
MAYNARD LEIGH |
4 113 |
0,06% |
Open Academy |
4 113 |
0,06% |
SHAPE HISTORY |
13 000 |
0,20% |
Rare Disease Day |
13 000 |
0,20% |
SWW INTERCULTURAL TRAINING |
2 200 |
0,03% |
Open Academy |
2 200 |
0,03% |
Grand Total |
75 748 |
1,16% |